- Home
- UE vs HRMY Comparison
UE vs HRMY Comparison
Compare UE & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UE
- HRMY
- Stock Information
- Founded
- UE 2014
- HRMY 2017
- Country
- UE United States
- HRMY United States
- Employees
- UE N/A
- HRMY N/A
- Industry
- UE Real Estate
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- UE Finance
- HRMY Health Care
- Exchange
- UE Nasdaq
- HRMY Nasdaq
- Market Cap
- UE 2.2B
- HRMY 2.0B
- IPO Year
- UE N/A
- HRMY 2020
- Fundamental
- Price
- UE $18.67
- HRMY $35.60
- Analyst Decision
- UE Hold
- HRMY Strong Buy
- Analyst Count
- UE 1
- HRMY 9
- Target Price
- UE $22.00
- HRMY $54.22
- AVG Volume (30 Days)
- UE 855.7K
- HRMY 650.3K
- Earning Date
- UE 07-30-2025
- HRMY 05-06-2025
- Dividend Yield
- UE 4.10%
- HRMY N/A
- EPS Growth
- UE N/A
- HRMY 13.13
- EPS
- UE 0.63
- HRMY 2.62
- Revenue
- UE $453,505,000.00
- HRMY $744,852,000.00
- Revenue This Year
- UE $6.42
- HRMY $20.35
- Revenue Next Year
- UE $4.60
- HRMY $17.42
- P/E Ratio
- UE $29.26
- HRMY $13.59
- Revenue Growth
- UE 8.73
- HRMY 20.62
- 52 Week Low
- UE $15.66
- HRMY $26.47
- 52 Week High
- UE $23.85
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- UE 56.53
- HRMY 62.50
- Support Level
- UE $17.87
- HRMY $34.50
- Resistance Level
- UE $18.33
- HRMY $35.96
- Average True Range (ATR)
- UE 0.32
- HRMY 0.98
- MACD
- UE 0.05
- HRMY -0.01
- Stochastic Oscillator
- UE 85.82
- HRMY 79.35
About UE Urban Edge Properties of Beneficial Interest
Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.